April 2018

In vivo assessment of the antipyretic activity of tilmicosin

The aim of the present study was to assess the antipyretic activity of the macrolide antibiotic, tilmicosin, at dose levels of 20 and 40 mg/kg of body weight, subcutaneously, in Brewer's yeast-induced fever model in mice. Pyrexia was induced by subcutaneous injection of 20 mL/kg of 20% (w/v) Brewer’s yeast suspension into the animal’s scruff region. Eighteen hours later, feverish animals were treated...

Author(s): A. M. El-Mahmoudy, I. M. Gheith, A. A. Elmajdoub and S. K. Awidat